KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Chemed (CHE) EBIT Margin (2016 - 2025)

Historic EBIT Margin for Chemed (CHE) over the last 17 years, with Q3 2025 value amounting to 11.96%.

  • Chemed's EBIT Margin fell 32400.0% to 11.96% in Q3 2025 from the same period last year, while for Sep 2025 it was 13.89%, marking a year-over-year decrease of 14200.0%. This contributed to the annual value of 15.07% for FY2024, which is 300.0% up from last year.
  • Latest data reveals that Chemed reported EBIT Margin of 11.96% as of Q3 2025, which was down 32400.0% from 11.0% recorded in Q2 2025.
  • Over the past 5 years, Chemed's EBIT Margin peaked at 19.01% during Q4 2023, and registered a low of 11.0% during Q2 2025.
  • For the 5-year period, Chemed's EBIT Margin averaged around 15.06%, with its median value being 15.2% (2024).
  • In the last 5 years, Chemed's EBIT Margin plummeted by -6981200bps in 2021 and then surged by 41300bps in 2023.
  • Chemed's EBIT Margin (Quarter) stood at 18.12% in 2021, then decreased by -18bps to 14.88% in 2022, then increased by 28bps to 19.01% in 2023, then fell by -6bps to 17.79% in 2024, then plummeted by -33bps to 11.96% in 2025.
  • Its last three reported values are 11.96% in Q3 2025, 11.0% for Q2 2025, and 14.65% during Q1 2025.